Cargando…
Comparison of the hepatic effects of nafenopin and WY-14,643 on peroxisome proliferation and cell replication in the rat and Syrian hamster.
Male Sprague-Dawley rats were fed control diet or diet containing 0.05% nafenopin (NAF) or 0.025% WY-14,643 (WY) and male Syrian hamsters were fed control diet or diet containing 0.25% NAF or 0.025% WY for periods of 1, 15, 40, and 60 weeks. Both NAF and WY produced a sustained increase in liver wei...
Autores principales: | Lake, B G, Evans, J G, Cunninghame, M E, Price, R J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
1993
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1519442/ https://www.ncbi.nlm.nih.gov/pubmed/8013414 |
Ejemplares similares
-
Characterization of WY 14,643 and its Complex with Aldose Reductase
por: Sawaya, Michael R., et al.
Publicado: (2016) -
Enhancement by Wy-14,643, a hepatic peroxisome proliferator, of diethylnitrosamine-initiated hepatic tumorigenesis in the rat.
por: Reddy, J. K., et al.
Publicado: (1978) -
Correlation between thyroid hormone status and hepatic hyperplasia and hypertrophy caused by the peroxisome proliferator-activated receptor alpha agonist Wy-14,643
por: Wang, C, et al.
Publicado: (2004) -
Nuclear Receptor PPARα Agonist Wy-14,643 Ameliorates Hepatic Cell Death in Hepatic IKKβ-Deficient Mice
por: Kim, Taehyeong, et al.
Publicado: (2017) -
Protective Effects of Peroxisome Proliferator-Activated Receptor-α Agonist, Wy14643, on Hypoxia/Reoxygenation Injury in Primary Rat Hepatocytes
por: Chen, Ke, et al.
Publicado: (2012)